Setién-Olarra A, Marichalar-Mendia X, Fernández-Pacheco JA, Fernández-Barriales-López M, Gainza-Cirauqui ML, Aguirre-Urizar JM. Validation of microRNA expression profile in Oral Lichenoid Disease through cytological samples. Med Oral Patol Oral Cir Bucal. 2019 Sep 1;24 (5):e610-4.  

 

doi:10.4317/medoral.23020

http://dx.doi.org/doi:10.4317/medoral.23020

____________________________________________________________________________________________________________________________________________________________

 

References

1. Cortés-Ramírez DA, Gainza-Cirauqui ML, Echebarria-Goikouria MA, Aguirre-Urizar JM. Oral lichenoid disease as a premalignant condition: the controversies and the unknown. Med Oral Patol Oral Cir Bucal. 2009; 14: E118-E122.

 

2. van der Waal, I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317-323.
https://doi.org/10.1016/j.oraloncology.2008.05.016
PMid:18674954

 

3. González-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008;14:229-243.
https://doi.org/10.1111/j.1601-0825.2008.01441.x
PMid:18298420

 

4. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;S2212-4403:31248-8.

 

5. Schwartz JL, Panda S, Beam C, Bach LE, Adami GR. RNA from brush oral cytology to measure squamous cell carcinoma gene expression. J Oral Pathol Med. 2008;37:70-7.
https://doi.org/10.1111/j.1600-0714.2007.00596.x
PMid:18197850

 

6. Acha-Sagredo A, Jiménez Y, Bagán JV, Echebarria-Goicouria MA, Aguirre-Urizar JM. Cytometric analysis of oral scrapings of patients with oral lichen planus. Cytopathology. 2011;22:106-10.
https://doi.org/10.1111/j.1365-2303.2010.00763.x
PMid:20497207

 

7. He Q, Chen Z, Cabay RJ, Zhang L, Luan X, Chen D, et al. microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol. 2016;57:15-20.
https://doi.org/10.1016/j.oraloncology.2016.03.017
PMid:27208839 PMCid:PMC4876012

 

8. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102-114.
https://doi.org/10.1038/nrg2290
PMid:18197166

 

9. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233.
https://doi.org/10.1016/j.cell.2009.01.002
PMid:19167326 PMCid:PMC3794896

 

10. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006;25:6188-6196.
https://doi.org/10.1038/sj.onc.1209913
PMid:17028598

 

11. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet. 2009;18:4818-4829.
https://doi.org/10.1093/hmg/ddp446
PMid:19776030

 

12. De Sarkar N, Roy R, Mitra JK, Ghose S, Chakraborty A, Paul RR, et al. A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancers. PLoS One. 2014;9:e104839.
https://doi.org/10.1371/journal.pone.0104839
PMid:25126847 PMCid:PMC4134240

 

13. Budhu A, Ji J, Wang XW. The clinical potential of microRNAs. J Hematol Oncol. 2010;3:37.
https://doi.org/10.1186/1756-8722-3-37
PMid:20925959 PMCid:PMC2958878

 

14. Yang Y, Li YX, Yang X, Jiang L, Zhou ZJ, Zhu YQ. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis. BMC Cancer. 2013;19:129.
https://doi.org/10.1186/1471-2407-13-129
PMid:23510112 PMCid:PMC3637283

 

15. Roy R, Singh R, Chattopadhyay E, Ray A, Sarkar ND, Aich R, et al. MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues. Gene. 2016;593:58-63.
https://doi.org/10.1016/j.gene.2016.08.011
PMid:27515006

 

16. Shi W, Yang J, Li S, Shan X, Liu X, Hua H, et al. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5. Oncotarget. 2015;24:40172-85.
https://doi.org/10.18632/oncotarget.5502
PMid:26474386 PMCid:PMC4741887

 

17. Setién-Olarra A, Bediaga NG, Acha-Sagredo A, Marichalar-Mendia X, de Pancorbo MM, Aguirre-Urizar JM. Genomewide miRNA profiling of oral lichenoid disorders and oral squamous cell carcinoma. Oral Dis. 2016;22:754-760.
https://doi.org/10.1111/odi.12536
PMid:27391377

 

18. Silverman S Jr. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg. 2000;58:1286-1288.
https://doi.org/10.1053/joms.2000.16630
PMid:11078141

 

19. Spivack SD, Hurteau GJ, Jain R, Kumar SV, Aldous KM, Gierthy JF, et al. Gene environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res. 2004;64:6805-13.
https://doi.org/10.1158/0008-5472.CAN-04-1771
PMid:15375000

 

20. Arao TC, Guimaraes AL, de Paula AM, Gomes CC, Gomez RS. Increased miRNA-146a and miRNA-155 expressions in oral lichen planus. Arch Dermatol Res. 2012;304:371-375.
https://doi.org/10.1007/s00403-011-1197-x
PMid:22139425

 

21. Gassling V, Hampe J, Acil Y, Braesen JH, Wiltfang J, Hasler R. Disease-associated miRNA-mRNA networks in oral lichen planus. PLoSOne. 2013;8:e63015.
https://doi.org/10.1371/journal.pone.0063015
PMid:23723971 PMCid:PMC3664564

 

22. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NFkappaB- dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103:12481-12486.
https://doi.org/10.1073/pnas.0605298103
PMid:16885212 PMCid:PMC1567904

 

23. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microRNA-146 suppresses NFkappa B activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008;27:5643-5647.
https://doi.org/10.1038/onc.2008.171
PMid:18504431 PMCid:PMC2811234

 

24. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 2008;18:131-140.
https://doi.org/10.1016/j.semcancer.2008.01.005
PMid:18291670

 

25. Zhang S, Hu F, Liang H, Liu Y, Yang J, Zhou W. Association between a miRNA-146a polymorphism and susceptibility to head and neck squamous cell carcinoma in Chinese patients: A meta-analysis of 8 case-control studies. PLoS One. 2017;12:e0186609.
https://doi.org/10.1371/journal.pone.0186609
PMid:29049342 PMCid:PMC5648221

 

26. Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ, Lin SC. Association between the rs2910164 polymorphism in premir- 146a and oral carcinoma progression. Oral Oncol. 2012;48:404-8.
https://doi.org/10.1016/j.oraloncology.2011.11.019
PMid:22182931

 

27. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, et al. MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 2008;68:3566-3572.
https://doi.org/10.1158/0008-5472.CAN-07-6639
PMid:18483236

 

28. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A, et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J. 2010;15:199-205.
https://doi.org/10.1042/BJ20100859
PMid:20819078 PMCid:PMC3130335

 

29. Zhao XD, Lu YY, Guo H, Xie HH, He LJ, Shen GF, et al. MicroRNA-7/NF-κB signaling regulatory feedback circuit regulates gastric carcinogenesis. J Cell Biol. 2015;210:613-27.
https://doi.org/10.1083/jcb.201501073
PMid:26261179 PMCid:PMC4539989

 

30. Anderson EC, Wong MH. Caught in the Akt: regulation of Wnt signaling in the intestine. Gastroenterology. 2010;139:718-722.
https://doi.org/10.1053/j.gastro.2010.07.012
PMid:20659460 PMCid:PMC3037729